First Flu Vax Made with GMO Insect Cells Hits the MarketHealthy Pregnancy, Baby & Child, Vaccination
Up until now, influenza vaccines have been manufactured with the use of egg cultures. With the growing number of people allergic to eggs, this has proved to be a stumbling block to the marketability of annual flu shots.
Ever aggressive in the quest to increase profits and consumer acceptance, the pharmaceutical industry has come up with a way to bypass the egg problem with the flu vaccine while simultaneously improving the bottom line.
Using proteins derived from GMO insect cells developed with the help of your tax dollars!
GMO vaccines are not something on the horizon either.
They are here.
Reports indicate that the FDA has very recently approved the first GMO vaccine known by the name Flublok.
The jab contains baculovirus, a GMO version of the insect virus created using recombinant DNA technology. Use of the technology is expected to speed production of vaccines, no doubt paving the way for a highly profitable product.
The Flublok package insert indicates that the vaccine is trivalent, meaning GM proteins from three different flu strains are used.
Instead of cells from egg cultures, Flublok is manufactured by Protein Sciences Corporation (PSC) using cells from the fall armyworm, a type of caterpillar.
The armyworm cells are genetically altered to produce large amounts of hemagglutinin, which is a flu virus protein that permits the flu virus itself to enter the human body more quickly.
Potential side effects from Flublok include allergic reactions, respiratory infections, headaches, fatigue, altered immunocompetence, rhinorrhea, and myalgia.
The package insert also warns that “careful consideration of the potential benefits and risks” of Flublok should be evaluated if the deadly nerve disease Gullain-Barre Syndrome (GSB) occurred within six weeks of receiving a prior flu vaccine.
Hard to believe someone who got Gullain-Barre from a prior flu jab would come back for more, don’t you think?
Most worrisome of all is that 2 study participants actually died during clinical trials of Flublok. True to pharmaceutical industry form, Protein Sciences Corporation insists the shot is safe, however, emphasizing that this new GMO shot is effective 45% of the time against all strains of flu and not just one or two.
It seems that the pharmaceutical industry is banking on the fact that even though the majority of people don’t want to eat GMOs, they will be willing to inject them.
Thanks but no thanks.
Sarah, The Healthy Home Economist
Two vaccine participants die during trials of the first GMO flu vaccine
Subscribe today and gain access to my exclusive & FREE weekly newsletter packed with the latest health news, Real Food recipes, video how-to's, special discounts and much more!